Trying on the underlying holdings of the ETFs in our protection universe at ETF Channel, we have now in contrast the buying and selling value of every holding in opposition to the typical analyst 12-month ahead goal value, and computed the weighted common implied analyst goal value for the ETF itself. For the iShares Russell 1000 Progress ETF (Image: IWF), we discovered that the implied analyst goal value for the ETF primarily based upon its underlying holdings is $467.59 per unit.
With IWF buying and selling at a current value close to $416.37 per unit, that signifies that analysts see 12.30% upside for this ETF trying by way of to the typical analyst targets of the underlying holdings. Three of IWF’s underlying holdings with notable upside to their analyst goal costs are Apellis Prescribed drugs Inc (Image: APLS), e.l.f. Magnificence Inc (Image: ELF), and Repligen Corp. (Image: RGEN). Though APLS has traded at a current value of $27.40/share, the typical analyst goal is 68.25% increased at $46.10/share. Equally, ELF has 33.82% upside from the current share value of $73.00 if the typical analyst goal value of $97.69/share is reached, and analysts on common expect RGEN to succeed in a goal value of $188.21/share, which is 28.11% above the current value of $146.92. Beneath is a twelve month value historical past chart evaluating the inventory efficiency of APLS, ELF, and RGEN:
Beneath is a abstract desk of the present analyst goal costs mentioned above:
| Identify | Image | Current Value | Avg. Analyst 12-Mo. Goal | % Upside to Goal |
|---|---|---|---|---|
| iShares Russell 1000 Progress ETF | IWF | $416.37 | $467.59 | 12.30% |
| Apellis Prescribed drugs Inc | APLS | $27.40 | $46.10 | 68.25% |
| e.l.f. Magnificence Inc | ELF | $73.00 | $97.69 | 33.82% |
| Repligen Corp. | RGEN | $146.92 | $188.21 | 28.11% |
Are analysts justified in these targets, or overly optimistic about the place these shares will likely be buying and selling 12 months from now? Do the analysts have a sound justification for his or her targets, or are they behind the curve on current firm and trade developments? A excessive value goal relative to a inventory’s buying and selling value can mirror optimism concerning the future, however will also be a precursor to focus on value downgrades if the targets had been a relic of the previous. These are questions that require additional investor analysis.
10 ETFs With Most Upside To Analyst Targets »
Additionally see:
Manufacturing Dividend Stock List
PDCO YTD Return
YOSH shares outstanding history
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
